TG Therapeutics reported 1.74M in Gross Profit on Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
TG Therapeutics TGTX:US 1.74M 341K
Amgen AMGN:US $ 5097M 208M
Ardelyx ARDX:US $ 1.17M 0.14M
Bayer BAYN:GR 5.89B 414M
Biogen BIIB:US $ 2267.1M 48.2M
Corcept Therapeutics CORT:US $ 94.86M 4.65M
Curis CRIS:US $ 2.89M 0.72M
Gilead Sciences GILD:US $ 6198M 1371M
Infinity Pharmaceuticals INFI:US $ 0.17M 0.03M
Intercept Pharmaceuticals ICPT:US $ 92.17M 3.79M
Johnson & Johnson JNJ:US $ 16088M 343M
Karyopharm Therapeutics KPTI:US $ 37.1M 15.64M
Novartis NOVN:VX 9.52B 21M
Ptc Therapeutics PTCT:US $ 132.2M 22.89M
Puma Biotechnology PBYI:US $ 35.97M 5.45M
Regeneron Pharmaceuticals REGN:US $ 2999.6M 1445.2M
Verastem VSTM:US $ 0M 0.5M
Vertex Pharmaceuticals VRTX:US $ 1747.65M 182.25M